Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests better bandages for bleeding cancer wounds

NCT ID NCT06581809

Symptom relief Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether special hemostatic dressings can reduce bleeding when changing bandages on bleeding cancer wounds. Four adults with malignant wounds participated. Researchers compared bleeding and pain between hemostatic and regular dressings. The goal was to find a better way to manage bleeding and improve comfort during wound care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4 people

The number who actually took part.

Started

Mar 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients 18 years and older; * Carriers of a malignant wound ≥ 10cm²; * Possibility of participating simultaneously in another research study without an exclusion period at the end of the study; * Patient having signed an informed consent Exclusion Criteria: * Patient under 18 years of age; * Non-ulcerated nodule, tumor infiltration; * Patient in the terminal phase of their cancer; * Patients with a tumor wound that is a cutaneous melanoma; * Patient refusing to be managed by a private nurse or hospitalization at home (HAD); * Pregnant or breast-feeding women * Persons deprived of liberty or under guardianship (including curatorship); * Persons of legal age under court protection; * Inability to participate in the study for geographical, social, or psychological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malignant wound are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malignant wound

Contacts and locations

Locations

  • CHU Saint Eloi

    Montpellier, 34090, France

  • CLCC - Institut Godinot

    Reims, 51100, France

  • Centre François Baclesse

    Caen, 14076, France

  • EHPAD Claude Goudet

    Marseillan, 34340, France

  • EHPAD Laurent Antoine

    Agde, 34300, France

  • EHPAD Pergolines

    Sète, 34207, France

  • EHPAD l'Estagnol

    Vias, 34450, France

  • Groupe Hospitalier Diaconesses Croix Saint Simon

    Paris, 75020, France

  • Hôpital Saint Clair

    Sète, 34200, France

  • Hôpital Saint-Loup

    Agde, 34300, France

  • Hôpital Tenon

    Paris, 75020, France

  • Institut Curie

    Paris, 75248, France